EAM Investors’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-67,143	Closed	-$4.81M	–	344
2023 Q4	$4.81M	Buy	+67,143	New	+$3.86M	0.85%	10
2023 Q3	–	Sell	-29,789	Closed	-$1.89M	–	397
2023 Q2	$1.89M	Buy	+29,789	New	+$1.86M	0.35%	114
2022 Q3	–	Sell	-32,849	Closed	-$1.88M	–	360
2022 Q2	$1.88M	Sell	32,849 -7,481	-19%	-$424K	0.46%	78
2022 Q1	$2.47M	Sell	40,330 -2,074	-5%	-$108K	0.46%	72
2021 Q4	$2.22M	Buy	+42,404	New	+$1.78M	0.36%	95
2021 Q3	–	Sell	-48,220	Closed	-$1.97M	–	408
2021 Q2	$1.97M	Buy	+48,220	New	+$1.78M	0.3%	138
2020 Q4	–	Sell	-38,600	Closed	-$990K	–	399
2020 Q3	$990K	Buy	+38,600	New	+$881K	0.23%	207
2016 Q3	–	Sell	-20,737	Closed	-$805K	–	372
2016 Q2	$805K	Sell	20,737 -9,861	-32%	-$354K	0.12%	279
2016 Q1	$851K	Sell	30,598 -75,645	-71%	-$2.52M	0.13%	270
2015 Q4	$5.71M	Buy	106,243 +11,075	+12%	+$559K	0.75%	6
2015 Q3	$3.81M	Sell	95,168 -57,221	-38%	-$1.87M	0.6%	23
2015 Q2	$4.87M	Buy	152,389 +106,257	+230%	+$2.69M	0.57%	30
2015 Q1	$1.1M	Buy	+46,132	New	+$1.03M	0.13%	295